BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

734 related articles for article (PubMed ID: 30565893)

  • 1. Evaluation of copy number variant detection from panel-based next-generation sequencing data.
    Yao R; Yu T; Qing Y; Wang J; Shen Y
    Mol Genet Genomic Med; 2019 Jan; 7(1):e00513. PubMed ID: 30565893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of copy number variation analysis for next-generation sequencing diagnostics.
    Ellingford JM; Campbell C; Barton S; Bhaskar S; Gupta S; Taylor RL; Sergouniotis PI; Horn B; Lamb JA; Michaelides M; Webster AR; Newman WG; Panda B; Ramsden SC; Black GC
    Eur J Hum Genet; 2017 Jun; 25(6):719-724. PubMed ID: 28378820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.
    Schenkel LC; Kerkhof J; Stuart A; Reilly J; Eng B; Woodside C; Levstik A; Howlett CJ; Rupar AC; Knoll JHM; Ainsworth P; Waye JS; Sadikovic B
    J Mol Diagn; 2016 Sep; 18(5):657-667. PubMed ID: 27376475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical analysis of germline copy number variation in DMD using a non-conjugate hierarchical Bayesian model.
    Kozareva V; Stroff C; Silver M; Freidin JF; Delaney NF
    BMC Med Genomics; 2018 Oct; 11(1):91. PubMed ID: 30342520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of New Copy Number Variation and the Evaluation of a CNV Detection Tool for NGS Panel Data in Polish Familial Hypercholesterolemia Patients.
    Rutkowska L; Pinkier I; Sałacińska K; Kępczyński Ł; Salachna D; Lewek J; Banach M; Matusik P; Starostecka E; Lewiński A; Płoski R; Stawiński P; Gach A
    Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing.
    Agiannitopoulos K; Pepe G; Tsaousis GN; Potska K; Bouzarelou D; Katseli A; Ntogka C; Meintani A; Tsoulos N; Giassas S; Venizelos V; Markopoulos C; Iosifidou R; Karageorgopoulou S; Christodoulou C; Natsiopoulos I; Papazisis K; Vasilaki-Antonatou M; Kabletsas E; Psyrri A; Ziogas D; Lalla E; Koumarianou A; Anastasakou K; Papadimitriou C; Ozmen V; Tansan S; Kaban K; Ozatli T; Eniu DT; Chiorean A; Blidaru A; Rinsma M; Papadopoulou E; Nasioulas G
    Cancer Genomics Proteomics; 2023; 20(5):448-455. PubMed ID: 37643779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of CNV detection tools for NGS panel data in genetic diagnostics.
    Moreno-Cabrera JM; Del Valle J; Castellanos E; Feliubadaló L; Pineda M; Brunet J; Serra E; Capellà G; Lázaro C; Gel B
    Eur J Hum Genet; 2020 Dec; 28(12):1645-1655. PubMed ID: 32561899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CNV-RF Is a Random Forest-Based Copy Number Variation Detection Method Using Next-Generation Sequencing.
    Onsongo G; Baughn LB; Bower M; Henzler C; Schomaker M; Silverstein KA; Thyagarajan B
    J Mol Diagn; 2016 Nov; 18(6):872-881. PubMed ID: 27597741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of next-generation sequencing gene panel diagnostics including copy-number variation analysis in 810 patients suspected of heritable thoracic aortic disorders.
    Overwater E; Marsili L; Baars MJH; Baas AF; van de Beek I; Dulfer E; van Hagen JM; Hilhorst-Hofstee Y; Kempers M; Krapels IP; Menke LA; Verhagen JMA; Yeung KK; Zwijnenburg PJG; Groenink M; van Rijn P; Weiss MM; Voorhoeve E; van Tintelen JP; Houweling AC; Maugeri A
    Hum Mutat; 2018 Sep; 39(9):1173-1192. PubMed ID: 29907982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CNV Detection from Exome Sequencing Data in Routine Diagnostics of Rare Genetic Disorders: Opportunities and Limitations.
    Royer-Bertrand B; Cisarova K; Niel-Butschi F; Mittaz-Crettol L; Fodstad H; Superti-Furga A
    Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Validation of Copy Number Variant Detection from Targeted Next-Generation Sequencing Panels.
    Kerkhof J; Schenkel LC; Reilly J; McRobbie S; Aref-Eshghi E; Stuart A; Rupar CA; Adams P; Hegele RA; Lin H; Rodenhiser D; Knoll J; Ainsworth PJ; Sadikovic B
    J Mol Diagn; 2017 Nov; 19(6):905-920. PubMed ID: 28818680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DeviCNV: detection and visualization of exon-level copy number variants in targeted next-generation sequencing data.
    Kang Y; Nam SH; Park KS; Kim Y; Kim JW; Lee E; Ko JM; Lee KA; Park I
    BMC Bioinformatics; 2018 Oct; 19(1):381. PubMed ID: 30326846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SeqCNV: a novel method for identification of copy number variations in targeted next-generation sequencing data.
    Chen Y; Zhao L; Wang Y; Cao M; Gelowani V; Xu M; Agrawal SA; Li Y; Daiger SP; Gibbs R; Wang F; Chen R
    BMC Bioinformatics; 2017 Mar; 18(1):147. PubMed ID: 28253855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free-access copy-number variant detection tools for targeted next-generation sequencing data.
    Roca I; González-Castro L; Fernández H; Couce ML; Fernández-Marmiesse A
    Mutat Res Rev Mutat Res; 2019; 779():114-125. PubMed ID: 31097148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting copy number variation in next generation sequencing data from diagnostic gene panels.
    Singh AK; Olsen MF; Lavik LAS; Vold T; Drabløs F; Sjursen W
    BMC Med Genomics; 2021 Aug; 14(1):214. PubMed ID: 34465341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of exon-level copy number variants in CytoScan XON assay and next-generation sequencing in clinical samples.
    Won D; Yeom E; Shin S; Lee ST; Rak Choi J
    Clin Chim Acta; 2024 Jun; 560():119703. PubMed ID: 38763467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent detection of targeted copy number variants and mutations using a myeloid malignancy next generation sequencing panel allows comprehensive genetic analysis using a single testing strategy.
    Shen W; Szankasi P; Sederberg M; Schumacher J; Frizzell KA; Gee EP; Patel JL; South ST; Xu X; Kelley TW
    Br J Haematol; 2016 Apr; 173(1):49-58. PubMed ID: 26728869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SILO: A Computational Method for Detecting Copy Number Gain in Clinical Specimens Analyzed on a Next-Generation Sequencing Platform.
    Miller N; Bouma M; Sabatini L; Gulukota K
    J Mol Diagn; 2021 Oct; 23(10):1241-1248. PubMed ID: 34365010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient detection of chromosome imbalances and single nucleotide variants using targeted sequencing in the clinical setting.
    Villela D; Costa SS; Vianna-Morgante AM; Krepischi ACV; Rosenberg C
    Eur J Med Genet; 2017 Dec; 60(12):667-674. PubMed ID: 28882788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-Generation Sequencing-Based Detection of Germline Copy Number Variations in BRCA1/BRCA2: Validation of a One-Step Diagnostic Workflow.
    Schmidt AY; Hansen TVO; Ahlborn LB; Jønson L; Yde CW; Nielsen FC
    J Mol Diagn; 2017 Nov; 19(6):809-816. PubMed ID: 28822785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.